Ruby Hall and Bajaj Finserv Unveil the World’s Most Advanced Cancer Technology, the CyberKnife S7

In a momentous collaboration, the Ruby Hall Clinic, in association with Bajaj Finserv, one of India's foremost and diversified financial services groups, is delighted to announce the inauguration of the cutting-edge CyberKnife S7. This revolutionary addition to the hospital's cancer treatment arsenal is made possible by Bajaj Finserv's CSR endeavors, reflecting their shared commitment to providing the finest care for cancer patients. With this, the hospital becomes the only one in Western Maharashtra with such advanced technology. Ruby Hall Clinic and Bajaj Finserv have a longstanding partnership in shaping the city's healthcare ecosystem and providing top-notch medical equipment to the people. The CyberKnife S7 by Accuray is the newest addition to their joint vision, which is an advanced robotic radiotherapy system that offers a revolutionary approach to cancer treatment. This cutting-edge technology is designed to deliver highly precise, non-invasive radiation therapy to target tumors with unparalleled accuracy. The system's intelligent capabilities enable real-time tracking and automatic adjustments, ensuring that the radiation is administered directly to the tumor, sparing surrounding healthy tissues. This precise targeting enhances treatment efficacy and reduces the risk of side effects, ultimately improving the patient's quality of life during the treatment process. The medical care team at Ruby Hall Clinic selected the latest generation CyberKnife S7 System to provide stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) to patients more efficiently, minimizing the time they spend in daily treatments and maximizing the number of cancer patients they can treat each day. This becomes all the more pertinent given the fact that a research paper published by the Indian Council of Medical Research in December last year estimated that cancer cases are likely to increase from 14.6 lakh in 2022 to 15.7 lakh in 2025 in India, making cancer one of the fastest-growing epidemics in the country.